Biocept, Inc. is a diagnostics company with commercialized assays for carcinomas and melanoma. The Company leverages its CNSide™ technology to provide physicians with clinically actionable information for treating and monitoring patients diagnosed with metastatic cancer involving the central nervous system (CNS). Visit www.biocept.com.
Contact this Exhibitor
Text
Cancel OK